Liver kinase B1 in exosomes inhibits immune checkpoint programmed death ligand 1 and metastatic progression of intrahepatic cholangiocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liver kinase B1 in exosomes inhibits immune checkpoint programmed death ligand 1 and metastatic progression of intrahepatic cholangiocarcinoma

Published:2022-07-15 Issue:3 Volume:48 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Liu Zhuo¹,Zhou Kunyan²,Zeng Jian¹,Zhou Xin¹,Li Huanyu¹,Peng Ke³,Liu Xiang¹,Feng Feng¹,Jiang Bin¹,Zhao Ming¹,Ma Tiexiang¹

Affiliation:

1. Third Department of General Surgery, The Central Hospital of Xiangtan, Xiangtan, Hunan 411100, P.R. China

2. Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, D‑30159 Hannover, Germany

3. Scientific Research Department, The Central Hospital of Xiangtan, Xiangtan, Hunan 411100, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference54 articles.

1. Pathogenesis, diagnosis, and management of cholangiocarcinoma;Rizvi;Gastroenterology,2013

2. Systemic therapies for intrahepatic cholangiocarcinoma;Kelley;J Hepatol,2020

3. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: A prospective case-series;Lunsford;Lancet Gastroenterol Hepatol,2018

4. Intrahepatic cholangiocarcinoma;El-Diwany;Surg Oncol Clin N Am,2019

5. A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity;Martin;Nature,2003

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma;Biomedicine & Pharmacotherapy;2024-06

2. Clinical significance of small extracellular vesicles in cholangiocarcinoma;Frontiers in Oncology;2024-04-11

3. WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses;Clinical and Experimental Medicine;2024-01-27

4. Revision of potential prognostic markers of cholangiocarcinoma for clinical practice;Expert Review of Anticancer Therapy;2023-04-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3